Editorial: Insights in thrombosis: 2022

Jonathan Douxfils; Hugo Ten Cate; Roberto Pola

doi:10.3389/fcvm.2023.1240626

Editorial: Insights in thrombosis: 2022

Front Cardiovasc Med. 2023 Jul 6:10:1240626. doi: 10.3389/fcvm.2023.1240626. eCollection 2023.

Authors

Jonathan Douxfils^{1

2}, Hugo Ten Cate³, Roberto Pola⁴

Affiliations

¹ Unité de Recherche en Pharmacologie Clinique et Toxicologie, Département de Pharmacie, Faculté de Médecine, Université de Namur, Namur, Belgium.
² QUALIblood s.a., QUALIresearch, Namur, Belgium.
³ Thrombosis Expertise Center and Carim School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, Netherlands.
⁴ Section of Internal Medicine and Thromboembolic Diseases, Department of Medicine and Geriatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

No abstract available

Keywords: antiplatelet therapy; antithrombotic; arterial thromboembolic event (ATE); direct oral anticoagulant (DOAC); factor XI inhibitors; factor v leiden; venous thrombembolism.

Publication types

Editorial